Drug
Enapotamab Vedotin
Enapotamab Vedotin: highest development phase Phase 1/2, developed by Genmab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Genmab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Enapotamab vedotin (HuMax-AXL-ADC) NCT02988817 | Phase 1/2 | Ovarian Cancer |
Latest
No recent events.
Follow Enapotamab Vedotin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.